natgillin/translations-raw huggingface dataset:
This Regulation does not affect the application of Directives on worker protection and the environment, especially Directive 2004/37/EC of the European Parliament and of the Council of 29 April 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (Sixth individual Directive within the meaning of Article 16(1) of Council Directive 89/391/EEC) [8] and Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical agents at work (fourteenth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC) [9] under which employers are required to eliminate dangerous substances, wherever technically possible, or to substitute dangerous substances with less dangerous substances.
Ta uredba ne vpliva na uporabo direktiv o varstvu delavcev in okolju, zlasti Direktive 2004/37/ES Evropskega parlamenta in Sveta z dne 29. aprila 2004 o varovanju delavcev pred nevarnostmi zaradi izpostavljenosti rakotvornim ali mutagenim snovem pri delu (šesta posebna direktiva v skladu s členom 16(1) Direktive Sveta 89/391/EGS) [8] in Direktive Sveta 98/24/ES z dne 7. aprila 1998 o varovanju zdravja in zagotavljanju varnosti delavcev pred tveganji zaradi izpostavljenosti kemičnim dejavnikom pri delu (štirinajsta posebna direktiva v smislu člena 16(1) Direktive 89/391/EGS) [9], v skladu s katero se od delodajalcev zahteva, da odstranijo nevarne snovi, če je to tehnično izvedljivo, ali jih nadomestijo z manj nevarnimi snovmi.
This Regulation should apply without prejudice to the prohibitions and restrictions laid down in Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products [10] in so far as substances are used and marketed as cosmetic ingredients and are within the scope of this Regulation.
Ta uredba bi se morala uporabljati brez poseganja v prepovedi in omejitve, določene v Direktivi Sveta 76/768/EGS z dne 27. julija 1976 o približevanju zakonodaj držav članic o kozmetičnih izdelkih [10], v kolikor se snovi uporabljajo in tržijo kot kozmetične sestavine in sodijo na področje uporabe te uredbe.
A phase-out of testing on vertebrate animals for the purpose of protecting human health as specified in Directive 76/768/EEC should take place with regard to the uses of those substances in cosmetics.
Postopno odpravljanje testiranja na vretenčarjih za namene varovanja zdravja ljudi, kakor je določeno v Direktivi 76/768/EGS, bi moralo potekati ob upoštevanju uporabe teh snovi v kozmetiki.
This Regulation will generate information on substances and their uses.
S to uredbo se pridobijo informacije o snoveh in njihovi uporabi.
Available information, including that generated by this Regulation, should be used by the relevant actors in the application and implementation of appropriate Community legislation, for example that covering products, and Community voluntary instruments, such as the eco-labelling scheme.
Razpoložljive informacije skupaj s tistimi, pridobljenimi po tej uredbi, bi morali udeleženci, na katere se to nanaša, uporabiti pri uporabi in izvajanju ustrezne zakonodaje Skupnosti, na primer zakonodaje o proizvodih, ter prostovoljnih instrumentov Skupnosti, kot je shema o ekološkem označevanju.
The Commission should consider in the review and development of relevant Community legislation and voluntary instruments how information generated by this Regulation should be used, and examine possibilities for establishing a European quality mark.
Komisija bi morala pri reviziji in pripravi ustrezne zakonodaje Skupnosti in prostovoljnih instrumentov upoštevati, kako bi se morale uporabiti informacije, pridobljene po tej uredbi, ter preučiti možnosti za oblikovanje evropske oznake kakovosti.
There is a need to ensure effective management of the technical, scientific and administrative aspects of this Regulation at Community level.
Obstaja potreba po zagotovitvi učinkovitega upravljanja tehničnih, znanstvenih in upravnih vidikov te uredbe na ravni Skupnosti.
A central entity should therefore be created to fulfil this role.
Za prevzem te naloge je zato treba ustanoviti osrednji subjekt.
A feasibility study on the resource requirements for this central entity concluded that an independent central entity offered a number of long-term advantages over other options.
Sklep študije o izvedljivosti zahtev v zvezi z viri za osrednji subjekt je bil, da zagotavlja samostojen osrednji subjekt v primerjavi z drugimi možnostmi vrsto dolgoročnih prednosti.
A European Chemicals Agency (hereinafter referred to as the Agency) should therefore be established.
Zato bi bilo treba ustanoviti Evropsko agencijo za kemikalije (v nadaljevanju „Agencija“).
This Regulation lays down specific duties and obligations on manufacturers, importers and downstream users of substances on their own, in preparations and in articles.
Ta uredba določa posebne dolžnosti in obveznosti proizvajalcev, uvoznikov in nadaljnjih uporabnikov snovi kot takih, snovi v pripravkih ali snovi v izdelkih.
This Regulation is based on the principle that industry should manufacture, import or use substances or place them on the market with such responsibility and care as may be required to ensure that, under reasonably foreseeable conditions, human health and the environment are not adversely affected.
Uredba temelji na načelu, da bi morala industrija proizvajati, uvažati, uporabljati snovi ali jih dajati na trg z vso potrebno odgovornostjo in skrbnostjo, ki zagotavlja, da pod razumno predvidljivimi pogoji uporabe nimajo negativnega učinka na zdravje ljudi ali okolje.
All available and relevant information on substances on their own, in preparations and in articles should be collected to assist in identifying hazardous properties, and recommendations about risk management measures should systematically be conveyed through supply chains, as reasonably necessary, to prevent adverse effects on human health and the environment.
Za ugotavljanje nevarnih lastnosti bi bilo treba zbrati vse dostopne in ustrezne informacije o snoveh kot takih, v pripravkih in v izdelkih; za preprečevanje škodljivih učinkov na zdravje ljudi in okolje pa bi se morala po dobavni verigi v razumni meri dosledno prenašati priporočila o ukrepih za obvladovanje tveganja.
In addition, communication of technical advice to support risk management should be encouraged in the supply chain, where appropriate.
Poleg tega bi bilo treba v dobavni verigi po potrebi spodbujati obveščanje o tehničnih nasvetih v podporo obvladovanju tveganja.
Responsibility for the management of the risks of substances should lie with the natural or legal persons that manufacture, import, place on the market or use these substances.
Za obvladovanje tveganja snovi bi morale odgovarjati fizične ali pravne osebe, ki te snovi proizvajajo, uvažajo, dajejo v promet ali jih uporabljajo.
Information on the implementation of this Regulation should be easily accessible, in particular for SMEs.
Informacije o izvajanju te uredbe bi morale biti lahko dostopne, zlasti za MSP.
Therefore, the registration provisions should require manufacturers and importers to generate data on the substances they manufacture or import, to use these data to assess the risks related to these substances and to develop and recommend appropriate risk management measures.
Zato bi morale določbe o registraciji od proizvajalcev in uvoznikov zahtevati, da pridobijo podatke o snoveh, ki jih proizvajajo ali uvažajo, in te podatke uporabijo za oceno tveganja, povezanega s to snovjo, ter da pripravijo in priporočijo ustrezne ukrepe za obvladovanje tveganja.
To ensure that they actually meet these obligations, as well as for transparency reasons, registration should require them to submit a dossier containing all this information to the Agency.
Z namenom zagotoviti, da se obveznosti dejansko izpolnjujejo, in iz razlogov preglednosti bi morala registracija zahtevati, da predložijo dokumentacijo z vsemi takšnimi informacijami Agenciji.
Registered substances should be allowed to circulate on the internal market.
Za registrirane snovi bi bilo treba dovoliti promet na notranjem trgu.
The evaluation provisions should provide for follow-up to registration, by allowing for checks on whether registrations are in compliance with the requirements of this Regulation and if necessary by allowing for generation of more information on the properties of substances.
V določbah o evalvaciji bi moralo biti predvideno spremljanje registracije, in sicer z omogočanjem preverjanja, ali so registracije v skladu z zahtevami iz te uredbe, in po potrebi z omogočanjem pridobivanja dodatnih informacij o lastnostih snovi.
If the Agency in cooperation with the Member States considers that there are grounds for considering that a substance constitutes a risk to human health or the environment, the Agency should, after having included the substance in the Community rolling action plan for substance evaluation, relying on the competent authorities of Member States, ensure that this substance is evaluated.
Če Agencija v sodelovanju z državo članico upravičeno meni, da je snov nevarna za zdravje ljudi ali okolje, bi morala Agencija, potem ko vključi snov v tekoč akcijski načrt Skupnosti za evalvacijo snovi, zagotoviti, da se te snovi evalvirajo, pri čemer se zanaša na pristojne organe držav članic.
Although the information yielded on substances through evaluation should be used in the first place by manufacturers and importers to manage the risks related to their substances, it may also be used to initiate the authorisation or restrictions procedures under this Regulation or risk management procedures under other Community legislation.
Čeprav so informacije o snoveh, pridobljene med evalvacijo, namenjene predvsem proizvajalcem in uvoznikom za uporabo pri obvladovanju tveganja, povezanega s temi snovmi, se te lahko uporabijo tudi za uvedbo postopkov avtorizacije ali določitev omejitev v skladu s to uredbo ali postopkov obvladovanja tveganja v skladu z drugo zakonodajo Skupnosti.
Therefore it should be ensured that this information is available to the competent authorities and may be used by them for the purpose of such procedures.
Zato bi bilo treba zagotoviti, da so te informacije na voljo pristojnim organom, ki jih lahko uporabijo za takšne postopke.
The authorisation provisions should ensure the good functioning of the internal market while assuring that the risks from substances of very high concern are properly controlled.
Določbe o avtorizaciji bi morale zagotoviti dobro delovanje notranjega trga in hkrati jamčiti, da se tveganja zaradi snovi, ki zbujajo veliko skrb, ustrezno nadzorujejo.
Authorisations for the placing on the market and use should be granted by the Commission only if the risks arising from their use are adequately controlled, where this is possible, or the use can be justified for socio-economic reasons and no suitable alternatives are available, which are economically and technically viable.
Avtorizacijo za dajanje v promet in uporabo bi morala Komisija izdati le, če se tveganje, ki izhaja iz njihove uporabe, ustrezno nadzoruje, kjer je to mogoče, ali če se lahko njihova uporaba utemelji s socialno-ekonomskimi razlogi in ni na voljo ustreznih drugih možnosti, ki so ekonomsko in tehnično izvedljive.
The restriction provisions should allow the manufacturing, placing on the market and use of substances presenting risks that need to be addressed, to be made subject to total or partial bans or other restrictions, based on an assessment of those risks.
Določbe o omejevanju bi morale omogočiti, da se proizvodnja, dajanje v promet in uporaba snovi, ki pomenijo tveganja, na katere se je treba odzvati, v celoti ali delno omeji ali prepove ali drugače omeji, na podlagi ocene teh tveganj.
In preparation for this Regulation, the Commission has launched REACH Implementation Projects (RIPs), involving relevant experts from stakeholder groups.
Pri pripravi te uredbe je Komisija sprožila izvedbene projekte REACH (RIP), ki vključujejo ustrezne strokovnjake iz interesnih skupin.
Some of those projects aim at developing draft guidelines and tools which should help the Commission, the Agency, Member States, manufacturers, importers and downstream users of substances to fulfil, in concrete terms, their obligations under this Regulation.
Nekateri od teh projektov skušajo oblikovati osnutek smernic in orodja, ki bi Komisiji, Agenciji, državam članicam, proizvajalcem, uvoznikom in nadaljnim uporabnikom snovi na konkreten način pomagale izpolniti njihove obveznosti na podlagi te uredbe.
This work should enable the Commission and the Agency to make available appropriate technical guidance, in due time, with regard to the deadlines introduced by this Regulation.
To delo bi moralo Komisiji in Agenciji omogočiti, da pravočasno zagotovita ustrezna tehnična navodila ob upoštevanju rokov, ki jih navaja ta uredba.
The responsibility to assess the risks and hazards of substances should be given, in the first place, to the natural or legal persons that manufacture or import substances, but only when they do so in quantities exceeding a certain volume, to enable them to carry the associated burden.
Odgovornost za ocenitev tveganj in nevarnosti snovi bi bilo zato treba zaupati predvsem fizičnim in pravnim osebam, ki te snovi proizvajajo ali uvažajo, vendar samo če to delajo v obsegu, ki presega določeno količino, da lahko tako nosijo s tem povezano obremenitev.
Natural or legal persons handling chemicals should take the necessary risk management measures in accordance with the assessment of the risks of substances and pass on relevant recommendations along the supply chain.
Fizične in pravne osebe, ki ravnajo s kemikalijami, bi morale sprejeti potrebne ukrepe za obvladovanje tveganja v skladu z oceno tveganja snovi, ki jih proizvajajo, in ustrezna sporočila posredovati po dobavni verigi.
This should include describing, documenting and notifying in an appropriate and transparent fashion the risks stemming from the production, use and disposal of each substance.
Med drugim bi to moralo vključevati ustrezen in pregleden opis ter uradno obvestilo o tveganjih, ki izvirajo iz proizvodnje, uporabe in odstranjevanja posamezne snovi.
In order to undertake chemical safety assessments of substances effectively, manufacturers and importers of substances should obtain information on these substances, if necessary by performing new tests.
Za učinkovito izvedbo ocene kemijske varnosti snovi bi morali proizvajalci in uvozniki snovi pridobiti informacije o teh snoveh, po potrebi z izvajanjem novih testov.
For purposes of enforcement and evaluation and for reasons of transparency, the information on these substances, as well as related information, including on risk management measures, should normally be submitted to authorities.
Za izvrševanje in evalvacijo ter zaradi preglednosti bi bilo treba informacije o teh snoveh in s tem povezane informacije, vključno z ukrepi za obvladovanje tveganja, praviloma predložiti organom.
Scientific research and development normally takes place in quantities below one tonne per year.
Pri znanstvenih raziskavah in razvoju se ponavadi uporabljajo količine, ki ne presegajo ene tone na leto.
There is no need to exempt such research and development because substances in those quantities do not have to be registered in any case.
Zato takšnih raziskav in razvoja ni treba izvzeti, saj snovi v teh količinah v nobenem primeru ni treba registrirati.
However, in order to encourage innovation, product and process oriented research and development should be exempted from the obligation to register for a certain time period where a substance is not yet intended to be placed on the market to an indefinite number of customers because its application in preparations or articles still requires further research and development performed by the potential registrant himself or in cooperation with a limited number of known customers.
Za spodbujanje inovativnosti bi bilo treba v proizvode in postopke usmerjene raziskave ter razvoj za določen čas izvzeti iz obveznega registriranja, če snov še ni namenjena za vstop na trg za nedoločeno število kupcev, ker njena uporaba v pripravkih ali izdelkih zahteva še dodatne raziskave in razvoj, ki jih opravi morebitni registracijski zavezanec sam ali v sodelovanju z omejenim številom znanih kupcev.
In addition, it is appropriate to provide for a similar exemption to downstream users using the substance for the purposes of product and process oriented research and development, provided that the risks to human health and the environment are adequately controlled in accordance with the requirements of legislation for the protection of workers and the environment.
Poleg tega je primerno, da se podobno izvzetje zagotovi za nadaljnje uporabnike, ki snovi uporabljajo za v proizvode in postopke usmerjene raziskave in razvoj, če so tveganja za zdravje ljudi in okolje ustrezno obvladovana v skladu z zahtevami zakonodaje za varovanje delavcev in okolja.
Since producers and importers of articles should be responsible for their articles, it is appropriate to impose a registration requirement on substances which are intended to be released from articles and have not been registered for that use.
Ker bi morali izdelovalci in uvozniki izdelkov odgovarjati za svoje izdelke, je primerno, da se uvede zahteva za registriranje snovi, ki naj bi se sprostile iz izdelkov in niso bile registrirane za to uporabo.
In the case of substances of very high concern which are present in articles above tonnage and concentration thresholds, where exposure to the substance cannot be excluded and where the substance has not been registered by any person for this use, the Agency should be notified.
Agencija bi morala biti obveščena glede snovi, ki zbujajo veliko skrb, količina in vsebnost katerih v izdelkih presegata zgornjo mejo, če se ne more izključiti izpostavljenosti snovem in kjer nihče ni registriral snovi za zadevno uporabo.
The Agency should also be empowered to request that a registration be submitted if it has grounds for suspecting that the release of a substance from the article may present a risk to human health or the environment and the substance is present in those articles in quantities totalling over one tonne per producer or importer per year.
Agencija bi morala biti pooblaščena tudi, da zahteva predložitev registracije, če utemeljeno sumi, da lahko sproščanje snovi iz izdelka škoduje zdravju ljudi in okolju ter da ti izdelki vsebujejo snov v količini, ki znaša skupaj več kot eno tono na leto na izdelovalca ali uvoznika.
The Agency should consider the need for a proposal for a restriction where it considers that the use of such substances in articles poses a risk to human health or the environment that is not adequately controlled.
Agencija bi morala razmisliti o predlogu za omejevanje za primere, v katerih meni, da uporaba takšnih snovi v izdelkih ogroža zdravje ljudi ali okolje in to ni ustrezno nadzorovano.
The requirements for undertaking chemical safety assessments by manufacturers and importers should be defined in detail in a technical annex to allow them to meet their obligations.
V tehnični prilogi bi bilo treba podrobno določiti zahteve za ocene kemijske varnosti, ki jih izvedejo proizvajalci in uvozniki, da lahko izpolnijo svoje obveznosti.
To achieve fair burden sharing with their customers, manufacturers and importers should in their chemical safety assessment address not only their own uses and the uses for which they place their substances on the market, but also all uses which their customers ask them to address.
Da se obremenitev pravično porazdeli s kupci, bi morali proizvajalci in uvozniki v svoji oceni kemijske varnosti poleg svojih uporab in uporab, za katere dajo snovi v promet, obravnavati tudi uporabe, za katere zaprosijo njihovi kupci.
The Commission, in close cooperation with industry, Member States and other relevant stakeholders, should develop guidance to fulfil the requirements under this Regulation related to preparations (in particular with regard to safety data sheets incorporating exposure scenarios) including assessment of substances incorporated into special preparations — such as metals incorporated in alloys.
Komisija bi morala v tesnem sodelovanju z industrijo, državami članicami in drugimi ustreznimi interesnimi skupinami oblikovati navodila za izpolnjevanje zahtev iz te uredbe v zvezi s pripravki (zlasti glede varnostnih listov, ki vključujejo scenarije izpostavljenosti), vključno z oceno snovi, vgrajenih v posebne pripravke – kakor npr. kovine v zlitinah.
In doing so, the Commission should take full account of the work that will have been carried out within the framework of the RIPs and should include the necessary guidance on this matter in the overall REACH guidance package.
Pri tem bi morala Komisija popolnoma upoštevati opravljeno delo v okviru RIP in bi morala v celotni sklop navodil REACH vključiti potrebna navodila na tem področju.
This guidance should be available before the application of this Regulation.
Ta navodila bi morala biti na voljo, preden se začne ta uredba uporabljati.
A chemical safety assessment should not need to be performed for substances in preparations in certain very small concentrations which are considered as not giving rise to concern.
Ocene kemijske varnosti ne bi bilo treba izvesti za snovi, ki jih vsebujejo pripravki v določenih, zelo majhnih koncentracijah, za katere velja, da ne zbujajo skrbi.
Substances in preparations in such low concentrations should also be exempt from authorisation.
Snovi, ki jih v tako nizkih koncentracijah vsebujejo pripravki, bi bilo tudi treba izvzeti iz avtorizacije.
These provisions should apply equally to preparations that are solid mixtures of substances until a specific shape is given to such a preparation that transforms it into an article.
Te določbe bi bilo treba enako uporabljati za pripravke, ki so trdne zmesi snovi, vse dokler ne dobijo določene oblike, ki jih spremeni v izdelek.
Joint submission and the sharing of information on substances should be provided for in order to increase the efficiency of the registration system, to reduce costs and to reduce testing on vertebrate animals.
Zagotoviti bi bilo treba skupno predložitev in souporabo informacij o snoveh, da bi se povečala učinkovitost registracijskega sistema ter zmanjšali stroški in testiranja na vretenčarjih.
One of a group of multiple registrants should submit information on behalf of the others according to rules which ensure that all the required information is submitted, while allowing sharing of the costs burden.
Eden iz skupine registracijskih zavezancev, ki predložijo registracijo za eno snov, bi moral v imenu drugih predložiti informacije v skladu s pravili, ki zagotavljajo predložitev vseh zahtevanih informacij ob hkratni porazdelitvi stroškovne obremenitve.
A registrant should be able to submit information directly to the Agency in certain specified cases.
Registracijskemu zavezancu bi bilo treba omogočiti, da lahko v določenih posebnih primerih predloži informacije neposredno Agenciji.
Requirements for generation of information on substances should be tiered according to the volumes of manufacture or importation of a substance, because these provide an indication of the potential for exposure of man and the environment to the substances, and should be described in detail.
Zahteve za pridobivanje informacij o snoveh bi bilo treba podrobno opisati in razvrstiti v skladu s proizvedeno ali uvoženo količino snovi, ker se na podlagi teh količin lahko določi, kakšna je verjetnost za izpostavljenost ljudi in okolja.
To reduce the possible impact on low volume substances, new toxicological and ecotoxicological information should only be required for priority substances between 1 and 10 tonnes.
Da bi zmanjšali morebiten vpliv na snovi v manjših količinah, se nove informacije o ekotoksikoloških in toksikoloških testih zahteva samo za prednostne snovi med 1 in 10 tonami.
For other substances in that quantity range there should be incentives to encourage manufacturers and importers to provide this information.
Za druge snovi v tem količinskem razponu morajo obstajati pobude za spodbujanje proizvajalcev in uvoznikov, da zagotavljajo te informacije.